Buzas, Edit I. http://orcid.org/0000-0002-3744-206X
Funding for this research was provided by:
EC | EC Seventh Framework Programm | FP7 Health (2019-2.1.7-ERA-NET-2021-00015)
Hungarian Government and European Commission
Article History
First Online: 30 August 2022
Competing interests
: The author is a member of the advisory board of Sphere Gene Therapeutics Inc. (Boston, USA).